Evidence map›Paper›PMID 24752249›Full record

ArticlePloS one2014

Rare mutations of CACNB2 found in autism spectrum disease-affected families alter calcium channel function.

Alexandra F S Breitenkamp, Jan Matthes, Robert Daniel Nass, Judith Sinzig, Gerd Lehmkuhl, Peter Nürnberg, Stefan Herzig

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Scalable and comprehensive mosaic variant calling using DRAGEN.medRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. CACNA1C-Related Channelopathies.Handbook of experimental pharmacology · 2023
    Review
  7. Article
  8. Article
  9. Inhibitory effects on L- and N-type calcium channels by a novel CaNaunyn-Schmiedeberg's archives of pharmacology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome.Pflugers Archiv : European journal of physiology · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Increased CaMolecular autism · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alexandra F S BreitenkampDepartment of Pharmacology, University of Cologne, Cologne, Germany.
Jan MatthesDepartment of Pharmacology, University of Cologne, Cologne, Germany.
Robert Daniel NassDepartment of Pharmacology, University of Cologne, Cologne, Germany.
Judith SinzigDepartment of Child and Adolescent Psychiatry and Psychotherapy, LVR-Klinik Bonn, Bonn, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Gerd LehmkuhlDepartment of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Peter NürnbergCologne Center for Genomics, University of Cologne, Cologne, Germany.
Stefan HerzigDepartment of Pharmacology, University of Cologne, Cologne, Germany; Center for Molecular Medicine, University of Cologne, Cologne, Germany.
University of Cologne · DE

Funding

Center for Genomic and Phenomic Studies in AutismU24MH081810 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAJONCHERE, CLARA M · 2007 to 2011
$8.3M
NIMH NIH HHS 1U24MH081810NIMH NIH HHS U24 MH081810
6 · The paper itself

Abstract

Autism Spectrum Disorders (ASD) are complex neurodevelopmental diseases clinically defined by dysfunction of social interaction. Dysregulation of cellular calcium homeostasis might be involved in ASD pathogenesis, and genes coding for the L-type calcium channel subunits CaV1.2 (CACNA1C) and CaVβ2 (CACNB2) were recently identified as risk loci for psychiatric diseases. Here, we present three rare missense mutations of CACNB2 (G167S, S197F, and F240L) found in ASD-affected families, two of them described here for the first time (G167S and F240L). All these mutations affect highly conserved regions while being absent in a sample of ethnically matched controls. We suggest the mutations to be of physiological relevance since they modulate whole-cell Ba2+ currents through calcium channels when expressed in a recombinant system (HEK-293 cells). Two mutations displayed significantly decelerated time-dependent inactivation as well as increased sensitivity of voltage-dependent inactivation. In contrast, the third mutation (F240L) showed significantly accelerated time-dependent inactivation. By altering the kinetic parameters, the mutations are reminiscent of the CACNA1C mutation causing Timothy Syndrome, a Mendelian disease presenting with ASD. In conclusion, the results of our first-time biophysical characterization of these three rare CACNB2 missense mutations identified in ASD patients support the hypothesis that calcium channel dysfunction may contribute to autism.

Indexed as

Ion Channel GatingAmino Acid SequenceBase SequenceCalcium Channels, L-TypeChild Development Disorders, PervasiveFamilyHEK293 CellsHumansMolecular Sequence DataPoint MutationRNA SplicingTime FactorsCACNB2 protein, humanCalcium Channels, L-Type

Identifiers

PMID24752249
PMCPMC3994086
OpenAlexW1976320686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.